Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Police probe side offers of COVID vaccines to Italian regions

Fri, 19th Feb 2021 17:39

By Emilio Parodi and Silvia Aloisi

MILAN, Italy, Feb 19 (Reuters) - Italian police are
investigating the offer of COVID-19 vaccines by unnamed
intermediaries to Veneto regional authorities, indicating a
possible attempt to create a black market parallel to the
national and EU level procurement process, two sources with
knowledge of the matter said on Friday.

Veneto governor Luca Zaia and regional health director
Luciano Flor said this week they were evaluating two offers they
received for a total of 27 million doses of the Pfizer
vaccine, without naming who had approached them.

Flor has said that the two offers were shortlisted from a
total of around 20 proposals the Veneto region had received from
various intermediaries in recent days, including some involving
AstraZeneca's vaccine and Russia's Sputnik one.

The approaches are unusual because the drugmakers that
manufacture the vaccines have struck deals with national
governments and, in the case of the European Union, with the EU
Commission, which has negotiated a procurement programme on
behalf of its members.

The Italian investigation is trying to establish whether a
parallel market had emerged, a source with direct knowledge of
the probe said. The source said it was not clear whether
drugmakers could legally sell their vaccines to non-governmental
entities in Europe.

"The regulatory framework is not clear at all," the source
told Reuters, speaking on condition of anonymity because the
probe is confidential and ongoing.

Andrew Widger, a spokesman for Pfizer, which has produced
its vaccine with German partner BioNTech, said
"currently, we are prioritising our available doses for supply
through established agreements with governments and
supra-government organisations".

"In the European Union, doses are supplied directly to
governments under the terms of the supply agreement with the
European Commission. No Pfizer/BioNTech vaccine is available
through intermediaries at this time," he added.

BioNTech did not immediately respond to a request for
comment.

A spokesman for AstraZeneca said the British-Swedish
drugmaker has not authorised any shipments of its vaccine
outside of its existing supply deal with the European Union.
There should not be any private-sector supply of the shots for
sale or distribution in Europe, he said.

The Russian Direct Investment Fund, Russia's sovereign
wealth fund which is responsible for marketing the Sputnik V
vaccine abroad, did not immediately reply to a request for
comment.

'DISTILLED WATER'

The EU Commission's head, Ursula von der Leyen, said this
week there were increasing cases of fraud and fraud attempts
related to coronavirus vaccines. She said the Commission was
taking action to bring those responsible to justice, adding it
could be extremely risky to take vaccines offered by black
market traders.

Zaia said on Friday he had asked his regional health
director Flor to write to Italy's NAS police, who specialise in
food and drugs fraud investigations, to inform them about the
vaccine offers.

Police visited the headquarters of the Veneto region on
Friday and took documents concerning the case, one of the
sources said.

"I welcome this operation (by the police) because it will
finally bring clarity and it will allow us to understand whether
we are dealing with fraudsters or not," Zaia told reporters.

Veneto has also contacted the national medicine agency AIFA
and Italy's special COVID-19 commissioner, Domenico Arcuri, to
ask them to evaluate whether the offers were legitimate.

"We have not conducted any negotiations on prices or
anything else as we are waiting to see if we can go ahead," Zaia
said. "We don't know if the vaccines are good or bad, if it's
just distilled water. We only did what we were bound to do - we
didn't go to the black market."

A spokesman for Arcuri confirmed the contacts with the
Veneto authorities, while AIFA had no comment.

In a related case, prosecutors in the central region of
Umbria are investigating a man who they say claimed to be a
legitimate trader and tried to sell doses of AstraZeneca
vaccines to regional authorities there.
(Additional reporting by Riccardo Bastianello in Padua, Ludwig
Burger in Frankfurt and Mike Erman in New York
Editing by Frances Kerry)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.